Image

Global Oligonucleotide Synthesis Market – Industry Trends & Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Mar 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Mar 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Oligonucleotide Synthesis Market, By Product (Oligonucleotide, Reagents and Equipment), Type (Custom Oligos and Predesigned Oligos), Application (Therapeutic Applications, Diagnostics, Research and Others), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Oligonucleotide Synthesis Market Market Analysis and Insights : Global Oligonucleotide Synthesis Market

The oligonucleotide synthesis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 17.3% in the forecast period of 2021 to 2028. The growing usage of synthesized oligos will help in escalating the growth of the oligonucleotide synthesis market.

Oligonucleotides are little remains of nucleic acids that are formed through enzymatic chemistry and genetic engineering. Oligonucleotides are mainly utilized in research laboratory for diagnostics, academic and industrial, and therapeutic functions. Oligonucleotide synthesis happens either commercially to provide facilities for several end-users or separately through DNA synthesizers for self-utilization. Presently, successive improvements in oligonucleotide synthesis, amplification, and computerization have entirely transformed biological research. It is also possible to do the customizations and get the necessary cycle online easily and at the necessary time. These essential services vary significantly by the expense of per base pair, error rates, lengths, and throughput, including others.

The growing usage of synthesized oligos in molecular diagnostics and clinical applications, the

cumulative government funds and research and development expenses in pharmaceutical and biotechnology companies, the increase in the venture capital savings are the major factors expected to boost the growth of the oligonucleotide synthesis market in the forecast period. However, the cost erosion of synthesized oligos, absence of a unified set of guidelines for therapeutic oligos are the reasons anticipated to most likely impede the growth of the oligonucleotide synthesis market during the forecast period. The advancing countries markets are to extend profitable opportunities. Despite that, the large-scale synthesis of oligos and the distribution of oligonucleotide drugs to particular targets will further challenge the growth of the oligonucleotide synthesis market in the coming years.

This Oligonucleotide Synthesis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Oligonucleotide Synthesis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Oligonucleotide Synthesis Market Scope and Market Size

The oligonucleotide synthesis market is segmented on the basis of product, type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • Based on the product, the oligonucleotide synthesis market into synthesized oligonucleotide, reagents and equipment.
  • Based on the type, the oligonucleotide synthesis market into custom oligos and predesigned oligos.
  • Based on the application, the oligonucleotide synthesis market into therapeutic applications, diagnostics, research and others.
  • Based on the end user, the oligonucleotide synthesis market into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories and others.

Oligonucleotide Synthesis Market Country Level Analysis

The oligonucleotide synthesis market is analysed and market size insights and trends are provided by country, product, type, application and end user as referenced above.      

The countries covered in the oligonucleotide synthesis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the oligonucleotide synthesis market due to the increasing R&D activities and the growing number of oligonucleotide-based drugs/therapies being approved by the FDA. Furthermore, the existence of better health care infrastructure and increasing usage of oligonucleotides by pharmaceutical companies of the region and many strategic collaborations among the players in the market will further boost the growth of the oligonucleotide synthesis market in the region. Europe is expected to observe significant amount of growth in the oligonucleotide synthesis market because of the presence of a well-established healthcare system and increasing initiatives by government bodies for the development of novel treatment options and is estimated to provide the market with high growth potential.  

The country section of the oligonucleotide synthesis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The oligonucleotide synthesis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Oligonucleotide Synthesis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the oligonucleotide synthesis market. The data is available for historic period 2010-2019.

Competitive Landscape and Oligonucleotide Synthesis Market Share Analysis

The oligonucleotide synthesis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to oligonucleotide synthesis market.

The major players covered in the oligonucleotide synthesis market report are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-
Why Choose Us


Frequently Asked Questions

The Oligonucleotide Synthesis Market is projected to grow at a CAGR of 17.3% during the forecast period by 2028.
The Oligonucleotide Synthesis Market is segmented on the basis of product, type, application and end user.
The major players in the Oligonucleotide Synthesis Market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, etc.
The countries covered in the Oligonucleotide Synthesis Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, etc.